Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hope

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled TrialJoseph N Jarvis, Tshepo B Leeme, Mooketsi Molefi, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Surgery|February 13, 2025
Expert consensus for key components of a high-quality ventral hernia repair operative noteJonathan S Lall, Said Maldonado, Nicole B Lyons, et al.
Trials|June 29, 2024
Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trialLydia Flett, Radwa Abdelatif, Sarah Akhtar Baz, et al.
Wellcome Open Research|February 26, 2019
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitisNguyen Thi Thuy Ngan, Nguyen Thi Hoang Mai, Nguyen Le Nhu Tung, et al.
Nature Reviews. Microbiology|June 25, 2024
The pathobiology of human fungal infectionsGordon D Brown, Elizabeth R Ballou, Steven Bates, et al.
The British Journal of Surgery|August 26, 2022
Updated guideline for closure of abdominal wall incisions from the European and American Hernia SocietiesEva B Deerenberg, Nadia A Henriksen, George A Antoniou, et al.
The Lancet Regional Health. Europe|September 24, 2021
Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for researchEsmita Charani, Martin McKee, Raheelah Ahmad, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled TrialJoseph N Jarvis, Tshepo B Leeme, Mooketsi Molefi, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Surgery|February 13, 2025
Expert consensus for key components of a high-quality ventral hernia repair operative noteJonathan S Lall, Said Maldonado, Nicole B Lyons, et al.
Trials|June 29, 2024
Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trialLydia Flett, Radwa Abdelatif, Sarah Akhtar Baz, et al.
Wellcome Open Research|February 26, 2019
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitisNguyen Thi Thuy Ngan, Nguyen Thi Hoang Mai, Nguyen Le Nhu Tung, et al.
Nature Reviews. Microbiology|June 25, 2024
The pathobiology of human fungal infectionsGordon D Brown, Elizabeth R Ballou, Steven Bates, et al.
The British Journal of Surgery|August 26, 2022
Updated guideline for closure of abdominal wall incisions from the European and American Hernia SocietiesEva B Deerenberg, Nadia A Henriksen, George A Antoniou, et al.
The Lancet Regional Health. Europe|September 24, 2021
Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for researchEsmita Charani, Martin McKee, Raheelah Ahmad, et al.
Pageof 16